Effects of a traditional Chinese herbal preparation on osteoblasts and osteoclasts

Maturitas

Volumn 61, Issue 4, 2008, Pages 334-339

  Zhang, Hong ^a   Xing, Wei Wei ^a,b   Li, Yu Shan ^b   Zhu, Zheng ^b,c   Wu, Jin Zhong ^d   Zhang, Qiao Yan ^a   Zhang, Wen ^a   Qin, Lu Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

^d FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Er Zhi Wan; Osteoporosis; Serum pharmacology; Traditional Chinese formulation

Indexed keywords

CHINESE DRUG; COLONY STIMULATING FACTOR 1; ER ZHI WAN; OSTEOCLAST DIFFERENTIATION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHINESE MEDICINE; CONTROLLED STUDY; DRUG MECHANISM; IN VITRO STUDY; MALE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; RAT;

ADMINISTRATION, ORAL; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DRUGS, CHINESE HERBAL; MALE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 57849156433     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.09.023     Document Type: Article

References (38)

1. Prabha S. Osteoporosis-a silent epidemic. Pharma Times 34 (2002) 21-22
2. Frost H.M. Perspectives: the role of changes in mechanical usage set points in the pathogenesis of osteoporosis. J Bone Miner Res 7 (1992) 253-261
3. Meryl S.L. In: Harris K., and Sludge R. (Eds). Metabolic Bone Diseases in Text Book of Rheumatology. 5th ed. (1997), Saunders, London 1563-1572
4. Genant H.K., Bay link D.J., and Gallagher J.C. Estrogens in the prevention of osteoporosis in post menopausal women. Am J Obstet Gynecol 161 (1998) 1842-1846
5. Bennet A.E., Wahner H.W., and Riggs B.L. Soya-a dietary source of the non steroidal oestrogen equal in man and animals. J Endocrinol 102 (1984) 49-56
6. Canalis H., McCarthy T., and Centrella M. Growth factors and the regulation on bone remodeling. J Clin Invest 81 (1998) 277-281
7. Qin L.P., Han T., Zhang Q.Y., et al. Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula. J Ethnopharmacol 118 (2008) 271-279
8. Cherdshewasart W., Bhuntaku P., Panriansaen R., Dahlan W., and Malaivijitnond S. Androgen disruption and toxicity tests of Butea superba Roxb., a traditional herb used for treatment of erectile dysfunction, in male rats. Maturitas 60 (2008) 131-137
9. Urasopon N., Hamada Y., Asaoka K., Cherdshewasart W., and Malaivijitnond S. Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats. Maturitas 56 (2007) 322-331
10. Li H., Yao M.J., Zhao W.M., Guan J., Cai L.L., and Cui L. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. J Chin Integr Med 6 (2008) 25-31
11. Zhang H., Han T., Sun L.N., Huang B.K., Chen Y.F., Zheng H.C., and Qin L.P. Regulative effects of essential oil from Atractylodes lancea on delayed gastric emptying in stress-induced rats. Phytomedicine 15 (2008) 602-611
12. Wang H.T., Wang Y.M., Liang Y.P., Liu Y.J., and Peng W. Wenyang Huoxue Recipe up-regulates the expression of angiopoietin-1 mRNA in rats with chronic aristolochic acid nephropathy. J Chin Integr Med 6 (2008) 508-511
13. The National Pharmacopoeia Commission of P.R. China. Pharmacopoeia of the People's Republic of China vol. 1 (2005), Chemical Industry Press, Beijing p. 293-4
14. Lu D.N. Effect of ER-ZHI-WAN on kidney disease. Henan Tradit Chin Med 27 (2007) 51-52
15. Tsai H.T., Lin H.Y., Fong Y.C., et al. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-κB pathway. Eur J Pharmacol 588 (2008) 124-133
16. Goldberg A.F., and Barka T. Acid phosphatase activity in human blood cells. Nature 189 (1962) 297
17. Sugawara K., Hamada M., Hosoi S., and Tamaoki T. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells. Anal Biochem 255 (1998) 204-210
18. Luo Z.G., Zhao Y., and Wang A.-T. Effect of serum containing Chinese herb of strengthening kidney on proliferation and differentiation of human osteoblast. Bone 38 (2006) 14
19. Cai J., Du J., and Cao Z.Y. Differential effects of different type of tonifying kidney on Mrna expression of estrogen receptor of amygdale cortical parietal lobe in male rats. J Fuji Coll TCM 16 (2006) 34-36
20. Zhang Y., Wong M.S., Chen B., Leung P.C., Wu C.F., and Yao X.S. Effect of Fructus Ligustri Lucidi on calcium metabolism and vitamin D-dependent gene expressions in ovariectomized rats. Chin Tradit Herb Drugs 37 (2006) 558-561
21. Tashino S. "Serum pharmacology" and "serum pharmaceutical chemistry": from pharmacology of Chinese traditional medicines to start a new measurement of drug concentration in blood. Ther Drug Monit Res 5 (1988) 54-64
22. Bochu W., Liancai Z., and Qi C. Primary study on the application of serum pharmacology in Chinese traditional medicine. Colloid Surf B Biointerf 43 (2005) 194-197
23. Sun J., Bi Y., Guo L., et al. Buyang Huanwu decoction promotes growth and differentiation of neural progenitor cells: using a serum pharmacological method. J Ethnopharmacol 113 (2007) 199-203
24. Zhou M.M., Yang K., Jiang Y.P., Wang Y.T., Chen K., and Wu L.Z. Study on methodology of serum pharmacology: influence of inactivation on drug containing serum. Chin Pharmacol Clin 15 (1999) 44-46
25. Triglia R.P., and Linscott W.D. Titers of nine complement components, conglutinin and C3 binactivator in adult and fetal bovine sera. Mol Immunol 17 (1980) 741-748
26. Shirwaikar A., Khan S., and Malini S. Antiosteoporotic effect of ethanol extract of Cissus quadrangularis Linn. on ovariectomized rat. J Ethnopharmacol 89 (2003) 245-250
27. Ye S.A., Saga I., Ichimura K., Nagai T., Shinoda M., and Matsuzaki S. Coumestrol as well as isoflavones in soybean extract prevent bone resorption in ovariectomized rats. Endocr Regul 37 (2003) 145-152
28. Nakagawa N., Kinosaki M., Yamaguchi K., et al. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 253 (1998) 395-400
29. Hsu H., Lacey D.L., Dunstan C.R., Solovyev I., Colombero A., and Timms E. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96 (1999) 3545-5340
30. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., and Mochizuki S. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclast inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95 (1998) 3597-3602
31. Wagner E.F., and Matsuo K. Signalling in osteoclasts and the role of Fos/AP1 proteins. Ann Rheum Dis 62 Suppl 2 (2003) ii83-ii85
32. Miyamoto T., Ohneda O., Arai F., et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98 (2001) 2544-2554
33. Fujikawa Y., Quinn J.M., Sabokbar A., McGee J.O., and Athanasou N.A. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137 (1996) 4058-4060
34. Robert L.J., and Stavros C.M. The cellular and biomechanical basis of bone remodeling. In: Marcus R. (Ed). Osteoporosis (1994), Blackwell Publications, London 22-23
35. Halleen J.M., Raisanen S.R., Alatalo S.L., and Vaananen H.K. Potential function for the ROS-generating activity of TRACP. J Bone Miner Res 18 (2003) 1908-1911
36. Halleen J.M., Raisanen S., Salo J.J., Reddy S.V., Roodman G.D., and Hentunen T.A. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 274 (1999) 22907-22910
37. Xiao X.H., Zhou H.D., and Wang Y.L. Osteoclastogenesis in RAW 264.7 cells induced by RANKL. Chin J Osteoporos 11 (2005) 151-155
38. Robert Y., and Yuan L. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol Ther 86 (2000) 191-198